Competition & Peer Data API & CSV Delivery

Achaogen Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Achaogen Inc (AKAO) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2018
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
8.35 %
Q4 2018
Net Margin
-2,346.81 %
Q4 2018

Key Findings: Achaogen Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 9M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-7.2% annualized vs trailing 12 months).
  • Peer revenue share: Achaogen Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

AKAO Sales vs. its Competitors, Q4 2018

Achaogen Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/AKAO/competitors
https://api.csimarket.com/api/v1/companies/AKAO/relationships
https://api.csimarket.com/api/v1/companies/AKAO/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Major Pharmaceutical Preparations industry grew revenue 7.2% year over year, combined, vs 8.4% for Achaogen Inc. Achaogen Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Achaogen Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Achaogen, Inc. No No No Yes
Similar Growth & Profitability (8) 0.00 % (0 of 8) 37.50 % (3 of 8) 37.50 % (3 of 8) 75.00 % (6 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q4 2018

100%market share
  • Achaogen Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Achaogen Inc and its 0 tracked competitors.

See Achaogen Inc's full market share breakdown »

AKAO Stock Performance relative to its Competitors

AKAO Competitors (weighted) Percent change over the selected range

AKAO Stock Performance relative to Similar Growth & Profitability Competitors

AKAO Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range